Cargando…

Bariatric endoscopy procedure type or follow-up: What predicted success at 1 year in 962 obese patients?

Background and study aims  It is uncertain if the difference in weight loss outcomes between different endoscopic bariatric therapies (EBTs) is technique-related or multidisciplinary team (MDT) follow-up-related. We hypothesized that at 1 year, the weight loss is determined more by adherence to MDT...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez-Nava, Gontrand, Asokkumar, Ravishankar, Rull, Angel, Corbelle, Fernandez, Beltran, Lucia, Bautista, Inmaculada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: © Georg Thieme Verlag KG 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887647/
https://www.ncbi.nlm.nih.gov/pubmed/31803819
http://dx.doi.org/10.1055/a-1007-1769
_version_ 1783475064016994304
author Lopez-Nava, Gontrand
Asokkumar, Ravishankar
Rull, Angel
Corbelle, Fernandez
Beltran, Lucia
Bautista, Inmaculada
author_facet Lopez-Nava, Gontrand
Asokkumar, Ravishankar
Rull, Angel
Corbelle, Fernandez
Beltran, Lucia
Bautista, Inmaculada
author_sort Lopez-Nava, Gontrand
collection PubMed
description Background and study aims  It is uncertain if the difference in weight loss outcomes between different endoscopic bariatric therapies (EBTs) is technique-related or multidisciplinary team (MDT) follow-up-related. We hypothesized that at 1 year, the weight loss is determined more by adherence to MDT follow-up than by procedure type. We aimed to compare 1 year weight loss outcomes of four different EBTs at a single center with a standardized MDT follow-up. Patients and methods  We prospectively collected and retrospectively analyzed outcomes in 962 patients (female-691, 71.2 %; mean age, 44.8 ± 10.6 years, mean BMI, 37.8 ± 5.9 Kg/m (2) ) treated with Intragastric balloons (IGBs) or endoscopic gastroplasty (EG) at HM Sanchinarro University Hospital between March 2012 to January 2017. The procedures were performed by the same endoscopist and followed up by the same MDT. We compared the percentage total body weight loss (%TWBL) at 1 year. We performed linear and logistic regression to identify predictive factors for weight loss and follow-up adherence at 1 year. Results  Four hundred and eighty-one IGBs (Orbera-80.9 %; ReShape Duo-19.1 %), and 481 EG (Apollo ESG-51.3 %; Primary obesity surgery endoluminal-POSE-48.6 %) were performed. Only 480 patients (IGB- 45 %; EG- 55 %) completed 1 year follow-up. Among them, Apollo ESG achieved significantly higher TBWL (19.5 ± 13 %, P  = 0.035), %TBWL (17.4 ± 10.2 %, P  = 0.025), and ≥ 20 % TBWL (36.7 %, P  = 0.032). However, in linear regression after adjusting for variables, only higher initial BMI (B = 0.31, P  < 0.001) and higher percentage follow-up attendance (B = 0.24, P  < 0.001) significantly predicted %TBWL at 1 year in the completion group but not the procedure type (B = 0.02, P  = 0.72). In logistic regression, we observed female sex ( P  = 0.01), high initial BMI ( P  < 0.001), endoscopic gastroplasty ( P  = 0.04), and high 1-month %TBWL ( P  < 0.001) significantly predicted follow-up completion at 1 year. Conclusions  Weight loss at 1 year is dependent on MDT follow-up rather than procedure type. Endoscopic gastroplasty promoted follow-up adherence more than IGBs.
format Online
Article
Text
id pubmed-6887647
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher © Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-68876472019-12-04 Bariatric endoscopy procedure type or follow-up: What predicted success at 1 year in 962 obese patients? Lopez-Nava, Gontrand Asokkumar, Ravishankar Rull, Angel Corbelle, Fernandez Beltran, Lucia Bautista, Inmaculada Endosc Int Open Background and study aims  It is uncertain if the difference in weight loss outcomes between different endoscopic bariatric therapies (EBTs) is technique-related or multidisciplinary team (MDT) follow-up-related. We hypothesized that at 1 year, the weight loss is determined more by adherence to MDT follow-up than by procedure type. We aimed to compare 1 year weight loss outcomes of four different EBTs at a single center with a standardized MDT follow-up. Patients and methods  We prospectively collected and retrospectively analyzed outcomes in 962 patients (female-691, 71.2 %; mean age, 44.8 ± 10.6 years, mean BMI, 37.8 ± 5.9 Kg/m (2) ) treated with Intragastric balloons (IGBs) or endoscopic gastroplasty (EG) at HM Sanchinarro University Hospital between March 2012 to January 2017. The procedures were performed by the same endoscopist and followed up by the same MDT. We compared the percentage total body weight loss (%TWBL) at 1 year. We performed linear and logistic regression to identify predictive factors for weight loss and follow-up adherence at 1 year. Results  Four hundred and eighty-one IGBs (Orbera-80.9 %; ReShape Duo-19.1 %), and 481 EG (Apollo ESG-51.3 %; Primary obesity surgery endoluminal-POSE-48.6 %) were performed. Only 480 patients (IGB- 45 %; EG- 55 %) completed 1 year follow-up. Among them, Apollo ESG achieved significantly higher TBWL (19.5 ± 13 %, P  = 0.035), %TBWL (17.4 ± 10.2 %, P  = 0.025), and ≥ 20 % TBWL (36.7 %, P  = 0.032). However, in linear regression after adjusting for variables, only higher initial BMI (B = 0.31, P  < 0.001) and higher percentage follow-up attendance (B = 0.24, P  < 0.001) significantly predicted %TBWL at 1 year in the completion group but not the procedure type (B = 0.02, P  = 0.72). In logistic regression, we observed female sex ( P  = 0.01), high initial BMI ( P  < 0.001), endoscopic gastroplasty ( P  = 0.04), and high 1-month %TBWL ( P  < 0.001) significantly predicted follow-up completion at 1 year. Conclusions  Weight loss at 1 year is dependent on MDT follow-up rather than procedure type. Endoscopic gastroplasty promoted follow-up adherence more than IGBs. © Georg Thieme Verlag KG 2019-12 2019-12-02 /pmc/articles/PMC6887647/ /pubmed/31803819 http://dx.doi.org/10.1055/a-1007-1769 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Lopez-Nava, Gontrand
Asokkumar, Ravishankar
Rull, Angel
Corbelle, Fernandez
Beltran, Lucia
Bautista, Inmaculada
Bariatric endoscopy procedure type or follow-up: What predicted success at 1 year in 962 obese patients?
title Bariatric endoscopy procedure type or follow-up: What predicted success at 1 year in 962 obese patients?
title_full Bariatric endoscopy procedure type or follow-up: What predicted success at 1 year in 962 obese patients?
title_fullStr Bariatric endoscopy procedure type or follow-up: What predicted success at 1 year in 962 obese patients?
title_full_unstemmed Bariatric endoscopy procedure type or follow-up: What predicted success at 1 year in 962 obese patients?
title_short Bariatric endoscopy procedure type or follow-up: What predicted success at 1 year in 962 obese patients?
title_sort bariatric endoscopy procedure type or follow-up: what predicted success at 1 year in 962 obese patients?
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887647/
https://www.ncbi.nlm.nih.gov/pubmed/31803819
http://dx.doi.org/10.1055/a-1007-1769
work_keys_str_mv AT lopeznavagontrand bariatricendoscopyproceduretypeorfollowupwhatpredictedsuccessat1yearin962obesepatients
AT asokkumarravishankar bariatricendoscopyproceduretypeorfollowupwhatpredictedsuccessat1yearin962obesepatients
AT rullangel bariatricendoscopyproceduretypeorfollowupwhatpredictedsuccessat1yearin962obesepatients
AT corbellefernandez bariatricendoscopyproceduretypeorfollowupwhatpredictedsuccessat1yearin962obesepatients
AT beltranlucia bariatricendoscopyproceduretypeorfollowupwhatpredictedsuccessat1yearin962obesepatients
AT bautistainmaculada bariatricendoscopyproceduretypeorfollowupwhatpredictedsuccessat1yearin962obesepatients